BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37088795)

  • 21. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
    Liu X; Li G
    Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wnt pathway targeting reduces triple-negative breast cancer aggressiveness through miRNA regulation in vitro and in vivo.
    Mohammadi-Yeganeh S; Hosseini V; Paryan M
    J Cell Physiol; 2019 Aug; 234(10):18317-18328. PubMed ID: 30945294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
    Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
    BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systems biology approach and in vitro experiment indicated Rapamycin targets key cancer and cell cycle-related genes and miRNAs in triple-negative breast cancer cells.
    Tafti A; Shojaei S; Zali H; Karima S; Mohammadi-Yeganeh S; Mondanizadeh M
    Mol Carcinog; 2023 Dec; 62(12):1960-1973. PubMed ID: 37787375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.
    Han C; Li X; Fan Q; Liu G; Yin J
    Aging (Albany NY); 2019 Jul; 11(14):4858-4875. PubMed ID: 31310241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-126-5p suppresses cell proliferation, invasion and migration by targeting EGFR in liver cancer.
    Zhao Y; Ye L; Yu Y
    Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):865-873. PubMed ID: 32409283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-122-5p promotes aggression and epithelial-mesenchymal transition in triple-negative breast cancer by suppressing charged multivesicular body protein 3 through mitogen-activated protein kinase signaling.
    Wang Z; Wang X
    J Cell Physiol; 2020 Mar; 235(3):2825-2835. PubMed ID: 31541468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-7 Exerts Antiangiogenic Effect on Colorectal Cancer via ERK Signaling.
    Fan X; Liu M; Tang H; Leng D; Hu S; Lu R; Wan W; Yuan S
    J Surg Res; 2019 Aug; 240():48-59. PubMed ID: 30909065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-940 Inhibited Cell Growth and Migration in Triple-Negative Breast Cancer.
    Hou L; Chen M; Yang H; Xing T; Li J; Li G; Zhang L; Deng S; Hu J; Zhao X; Jiang J
    Med Sci Monit; 2016 Oct; 22():3666-3672. PubMed ID: 27731867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. lncRNA GHET1 Promotes the Progression of Triple-Negative Breast Cancer
    Wang Y; Li C
    Comput Math Methods Med; 2022; 2022():8366569. PubMed ID: 35509860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-192-5p inhibits migration of triple negative breast cancer cells and directly regulates Rho GTPase activating protein 19.
    Vajen B; Greiwe L; Schäffer V; Eilers M; Huge N; Stalke A; Schlegelberger B; Illig T; Skawran B
    Genes Chromosomes Cancer; 2021 Nov; 60(11):733-742. PubMed ID: 34296808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells.
    Wu J; Li WZ; Huang ML; Wei HL; Wang T; Fan J; Li NL; Ling R
    Biochem Biophys Res Commun; 2017 Jan; 483(1):10-16. PubMed ID: 28069384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA‑27a promotes tumorigenesis via targeting AKT in triple negative breast cancer.
    Wu J; Sun Z; Sun H; Li Y
    Mol Med Rep; 2018 Jan; 17(1):562-570. PubMed ID: 29115608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-137 Inhibits Cancer Progression by Targeting Del-1 in Triple-Negative Breast Cancer Cells.
    Lee SJ; Jeong JH; Kang SH; Kang J; Kim EA; Lee J; Jung JH; Park HY; Chae YS
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-496 inhibits triple negative breast cancer cell proliferation by targeting Del-1.
    Lee SJ; Jeong JH; Lee J; Park HY; Jung JH; Kang J; Kim EA; Park NJ; Park JY; Lee IH; Chae YS
    Medicine (Baltimore); 2021 Apr; 100(14):e25270. PubMed ID: 33832090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of miR-205 contributes to epithelial-mesenchymal transition and invasion in triple-negative breast cancer by targeting HMGB1-RAGE signaling pathway.
    Wang L; Kang FB; Wang J; Yang C; He DW
    Anticancer Drugs; 2019 Mar; 30(3):225-232. PubMed ID: 30334817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells.
    Wang C; Zheng X; Shen C; Shi Y
    J Exp Clin Cancer Res; 2012 Jun; 31(1):58. PubMed ID: 22713668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation.
    Drago-Ferrante R; Pentimalli F; Carlisi D; De Blasio A; Saliba C; Baldacchino S; Degaetano J; Debono J; Caruana-Dingli G; Grech G; Scerri C; Tesoriere G; Giordano A; Vento R; Di Fiore R
    Oncotarget; 2017 Apr; 8(17):28939-28958. PubMed ID: 28423652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.